540 related articles for article (PubMed ID: 3093307)
1. [Inhibition of ovulation with 35 micrograms of ethinyl estradiol and 2 mg of cyproterone acetate (Diane 35)].
Spona J; Huber J; Schmidt JB
Geburtshilfe Frauenheilkd; 1986 Jul; 46(7):435-8. PubMed ID: 3093307
[TBL] [Abstract][Full Text] [Related]
2. [Clinical experience with Diane-35, currently the lowest dose antiandrogenic hormonal ovulation inhibitor, in mild to moderative androgenization in the female].
Kaiser E
Geburtshilfe Frauenheilkd; 1986 Oct; 46(10):738-42. PubMed ID: 2948866
[TBL] [Abstract][Full Text] [Related]
3. Treatment of idiopathic hirsute women with two combinations of cyproterone acetate.
Salva P; Morer F; Ordoñez J; Rodriguez J
Int J Clin Pharmacol Res; 1983; 3(2):129-35. PubMed ID: 6237068
[TBL] [Abstract][Full Text] [Related]
4. [Clinical use of antiandrogens in the female].
Moltz L; Schwartz U; Hammerstein J
Gynakologe; 1980 Mar; 13(1):1-17. PubMed ID: 6299908
[TBL] [Abstract][Full Text] [Related]
5. Effects of a low-dose estrogen-antiandrogen combination (Diane-35) on clinical signs of androgenization, hormone profile and ovarian size in patients with polycystic ovary syndrome.
Prelević GM; Würzburger MI; Balint-Perić L; Puzigaća Z
Gynecol Endocrinol; 1989 Dec; 3(4):269-80. PubMed ID: 2516704
[TBL] [Abstract][Full Text] [Related]
6. A new association of ethinylestradiol (0.035 mg) cyproterone acetate (2 mg) in the therapy of polycystic ovary syndrome.
Falsetti L; Dordoni D; Gastaldi C; Gastaldi A
Acta Eur Fertil; 1986; 17(1):19-25. PubMed ID: 2941960
[TBL] [Abstract][Full Text] [Related]
7. [The efficacy of gestoden (delta 15-d-norgestrel) as ovulation inhibitor (author's transl)].
Schneider WH; Schmid R; Spona J
Wien Klin Wochenschr; 1981 Oct; 93(19):601-4. PubMed ID: 6798765
[TBL] [Abstract][Full Text] [Related]
8. [A new ovulation inhibitor antiandrogen].
Millet-part A; Blanes-espi A; Ferrer-barriendos J; Siqueira L; Acosta E
J Bras Ginecol; 1984 Mar; 94(3):91-7. PubMed ID: 12266391
[TBL] [Abstract][Full Text] [Related]
9. [Management of virilization with an antiandrogen-containing contraceptive].
Apró G; Sas M
Orv Hetil; 1981 Jul; 122(30):1821-4. PubMed ID: 6458007
[TBL] [Abstract][Full Text] [Related]
10. Urinary 6-sulfatoxymelatonin excretion in hyperandrogenic women: the effect of cyproterone acetate-ethinyl estradiol treatment.
Luboshitzky R; Herer P; Shen-Orr Z
Exp Clin Endocrinol Diabetes; 2004 Feb; 112(2):102-7. PubMed ID: 15031776
[TBL] [Abstract][Full Text] [Related]
11. [Ovarian suppression with Diane 35/50].
Erdmann D; Schindler EM; Schindler AE
Geburtshilfe Frauenheilkd; 1994 Nov; 54(11):627-33. PubMed ID: 8719015
[TBL] [Abstract][Full Text] [Related]
12. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
Cianci A; De Leo V
Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
[TBL] [Abstract][Full Text] [Related]
13. An open study of Triphasil and Diane 50 in the treatment of acne.
Wishart JM
Australas J Dermatol; 1991; 32(1):51-4. PubMed ID: 1834045
[TBL] [Abstract][Full Text] [Related]
14. [Long-term studies with an anti-androgen/estrogen combination preparation of its effectiveness, liver tolerance and lipid metabolism in females].
Kaiser E; Gruner S
Geburtshilfe Frauenheilkd; 1991 Apr; 51(4):298-303. PubMed ID: 1830560
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of ovulation by a new low-dose monophasic contraceptive containing gestodene.
Thomas KH; Vankrieken L
Int J Fertil; 1989 Sep; 34 Suppl():10-21. PubMed ID: 2576249
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of moderately severe virilism of women with Diane and Androcur 10].
Döring HF; Ilgner M
Z Hautkr; 1983 May; 58(10):761-7. PubMed ID: 6224353
[TBL] [Abstract][Full Text] [Related]
17. [Effect of ethinyl estradiol-dienogest combination on serum androgen concentrations].
Oettel M; Carol W; Gräser T; Klinger G; Mellinger U; Moore C; Schindler AE; Winkler UH
Zentralbl Gynakol; 1997; 119(12):597-606. PubMed ID: 9483810
[TBL] [Abstract][Full Text] [Related]
18. Long-term treatment of hirsutism: desogestrel compared with cyproterone acetate in oral contraceptives.
Porcile A; Gallardo E
Fertil Steril; 1991 May; 55(5):877-81. PubMed ID: 1827074
[TBL] [Abstract][Full Text] [Related]
19. [Reduced estrogen ovulation inhibitor in acne therapy. Double-blind study comparing Diane-35 to Diane].
Aydinlik S; Lachnit-Fixson U; Lehnert J
Fortschr Med; 1986 Jul; 104(27-28):547-50. PubMed ID: 2943651
[No Abstract] [Full Text] [Related]
20. [Plasma concentrations of LH and of sex steroids during the normal menstrual cycle and during contraceptive treatment].
Bayard F; Louvet JP; Moatti JP; Smilovici W; Duguet L; Boulard C
J Gynecol Obstet Biol Reprod (Paris); 1975; 4(7):915-26. PubMed ID: 767402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]